4.7 Article

A functional polysaccharide from Eriobotrya japonica relieves myocardial ischemia injury via anti-oxidative and anti-inflammatory effects

Journal

FOOD & FUNCTION
Volume 13, Issue 1, Pages 113-120

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1fo03208a

Keywords

-

Funding

  1. National Natural Science Foundation of China [NSFC 82003922]
  2. Key Research and Discovery Program of Shandong Province [2019GSF107072]
  3. Natural Science Foundation of Shandong [ZR2020QH322]
  4. High-Level Talent Research Foundation of Qingdao Agricultural University, China [1119007]

Ask authors/readers for more resources

The food-derived polysaccharide EJP showed significant protective effects against myocardial ischemia reperfusion injury by exhibiting anti-inflammatory and antioxidative activities, and also demonstrated protective effects on both the heart and kidneys.
We herein report a food-derived polysaccharide (EJP) with the effect of relieving myocardial ischemia reperfusion injury (MIRI). This novel polysaccharide was isolated from the leaf of Eriobotrya japonica, and we first found its myocardium protective effects in vitro. Then, we firstly characterized EJP with a series of analytical technologies and further tested its effect on myocardial ischemia reperfusion injury (MIRI) with the illustration of the potential mechanisms in vivo. Interestingly, in the murine model of MIRI, administration of EJP effectively improved post-I/R heart contraction and limited the infarct size. Moreover, EJP significantly attenuated IR-induced oxidative damage and inflammatory reaction, as evidenced by decreasing MDA, IL-6, and TNF-alpha contents and increasing SOD activity and GSH-Px expression. In addition, we proved that EJP not only had no nephrotoxicity but also demonstrated a protective effect on the kidneys through HE staining and biochemical analysis. In sum, EJP, with a significant protective effect against myocardial I/R injury by showing anti-inflammatory and anti-oxidative activities, may become a meaningful drug candidate for the treatment of myocardial I/R injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available